Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns
Adrián Ricarte, James A. R. Dalton, Jesús Giraldo
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 3, pp. 1251-1274
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Youwen Zhuang, Yue Wang, Bingqing He, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4361-4375.e19
Open Access | Times Cited: 155
The anomalous pharmacology of fentanyl
Eamonn Kelly, Katy J. Sutcliffe, Damiana Cavallo, et al.
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 797-812
Closed Access | Times Cited: 93
Treatment of overdose in the synthetic opioid era
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 85
The role of the methoxy group in approved drugs
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 15
Fentanyl and its derivatives: Pain-killers or man-killers?
Jiří Patočka, Wenda Wu, Patrik Olekšák, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e28795-e28795
Open Access | Times Cited: 13
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 22
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, et al.
Psychopharmacology (2023) Vol. 240, Iss. 12, pp. 2573-2584
Closed Access | Times Cited: 18
Engineering Innervated Musculoskeletal Tissues for Regenerative Orthopedics and Disease Modeling
Zhilong Zhou, Jun Liu, Tiandi Xiong, et al.
Small (2024) Vol. 20, Iss. 23
Open Access | Times Cited: 6
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists
Maria Antonietta De Luca, Graziella Tocco, Rafaela Mostallino, et al.
Neuropharmacology (2022) Vol. 221, pp. 109263-109263
Open Access | Times Cited: 28
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor
Nokomis Ramos‐Gonzalez, Sam Groom, Katy J. Sutcliffe, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 18, pp. 2341-2360
Open Access | Times Cited: 15
Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl
Bing Xie, Valerie P. Le Rouzic, Alexander Goldberg, et al.
Neuropharmacology (2023) Vol. 227, pp. 109442-109442
Open Access | Times Cited: 14
A bridged backbone strategy enables collective synthesis of strychnan alkaloids
Wenqiang Zhou, Song Xi, Haohua Chen, et al.
Nature Chemistry (2023) Vol. 15, Iss. 8, pp. 1074-1082
Closed Access | Times Cited: 13
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Ying Han, Lu Cao, Kai Yuan, et al.
Neuroscience Bulletin (2022) Vol. 38, Iss. 11, pp. 1365-1382
Open Access | Times Cited: 19
Fentanyl and the Fluorinated Fentanyl Derivative NFEPP Elicit Distinct Hydrogen-Bond Dynamics of the Opioid Receptor
Samo Lešnik, Urban Bren, Tatiana Domratcheva, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4732-4748
Closed Access | Times Cited: 11
Mitragynine and Morphine Stabilize Different Conformations of the Μ-Opioid Receptor as Revealed by Molecular Dynamics Simulation Studies
Joydip Das, Jonathan P. Mathews, Netra Prasad Neupane, et al.
(2025)
Closed Access
Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid Receptor
David A. Cooper, Joseph DePaolo-Boisvert, Stanley A. Nicholson, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Xylazine potentiates the interoceptive effects of fentanyl in male and female rats
Brooke N. Bender, John D. Carew, Madigan L. Bedard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Rational Design Biased Compounds against μ-Opioid Receptor
Chenyang Wu, Yi Li, Horst Vogel, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Implementing physics-based digital patient twins to tailor the switch of oral morphine to transdermal fentanyl patches based on patient physiology
Flora Bahrami, René M. Rossi, Katelijne De Nys, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 195, pp. 106727-106727
Open Access | Times Cited: 3
A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor
Bing Xie, Alexander Goldberg, Lei Shi
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2309-2321
Open Access | Times Cited: 14
Low concentrations of tricyclic antidepressants stimulate TRPC4 channel activity by acting as an opioid receptor ligand
Byeongseok Jeong, Young Pyo Song, Ji Yeon Chung, et al.
AJP Cell Physiology (2023) Vol. 324, Iss. 6, pp. C1295-C1306
Closed Access | Times Cited: 7
Aniquinazoline B, a Fungal Natural Product, Activates the μ‐Opioid Receptor
Roxana Damiescu, Mohamed Elbadawi, Mona Dawood, et al.
ChemMedChem (2024) Vol. 19, Iss. 19
Closed Access | Times Cited: 2
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs
John J. Mariani, Robert L. Dobbins, Amy Heath, et al.
American Journal on Addictions (2023) Vol. 33, Iss. 1, pp. 8-14
Open Access | Times Cited: 6
Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics
Piotr F. J. Lipiński, Joanna Matalińska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2766-2766
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top